MYP_025125
Basic Information
Octreotide acetate
Used for treatment of acromegaly
Standard
8 amino acids
C40H63N9O15S
Standard
Sequence
LCYSTEIN
Physicochemical Analysis
942.04 Da
4.05
-1.25
-1.47
-0.1560
0.12
0.14
0.15
56.90
97.50
0.1250
1490.00
1490.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
408.10
-4.12
15.0
15.0
29.0
65.0
1.0
8.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0094364 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Somatostatin
32630
Structure & Mods
disulfide-constrained cyclic peptide [Cyclic]
mixed L/D amino-acid peptide [Mixed]
None
None
2-7
2-hydroxy-1-(hydroxymethyl)
Bio-Activity Profile
Used for treatment of acromegaly
EIA
Mice blood serum (oral delivery in 0.5% Intravail), in vivo; 3126 s